Technology | Stents Bare Metal | December 14, 2017

FDA Approves New Indication for NuMed CP Stent System

Covered stent may now be used to patch blood vessel tears during transcatheter valve replacements

FDA Approves New Indication for NuMed CP Stent System

December 14, 2017 — The U.S. Food and Drug Administration (FDA) announced clearance for NuMed’s Cheatham Platinum (CP) Stent System, which includes the Covered CP Stent and the Covered Mounted CP Stent. The Covered CP Stent is a metal framework covered with cloth to patch a blood vessel tear in patients born with heart defects. The device was approved previously to reopen a blocked or narrowed aorta.

The stents are compressed and placed using a balloon-in-balloon (BiB) catheter. The catheter is inserted through the skin in the upper leg (groin) and pushed through the blood vessels until it reaches the target location. The stent is then expanded with the balloon. Once the stent is in place, the balloon catheter is removed from the body.

Patients born with heart defects often receive a pulmonary valve conduit (a tube with a valve inside), also known as a right ventricular outflow tract (RVOT) conduit. The RVOT conduit is used to correct the defects. Over time, the conduit may become narrowed or leaky and will need to be replaced. If a patient who has previously had a conduit implanted needs a new pulmonic valve, one option for replacement is the use of a transcatheter heart valve (THV). As part of the procedure to replace the pulmonic valve a BiB catheter is used to widen the area where the new valve will be located. Sometimes, this process causes the RVOT conduit to rupture or tear. The Covered CP Stent is used to cover the tear in the conduit before implanting a THV.

If the Covered CP stent is able to successfully close the tear in the RVOT conduit, the surgeon may be able to continue implanting the new THV. If this approach is possible, the new valve can be implanted without open-heart surgery. In a clinical study of 50 patients, about 9 out of 10 had successful closure of the conduit tear with use of the Covered CP Stent followed by successful implantation of a pulmonic valve.

  • The Covered CP Stents should not be used in patients who:
  • Are too small to allow safe delivery of the stent without injury to a systemic vein or to the right side of the heart;
  • Exhibit clinical or biological signs of infection;
  • Have active infection in the heart (endocarditis); and/or
  • Are pregnant.

For more information: www.numedinc.com


Related Content

News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
Subscribe Now